Leucine-Rich Repeat Kinase 2 Is Associated With Activation of the Paraventricular Nucleus of the Hypothalamus and Stress-Related Gastrointestinal Dysmotility.
LRRK2
gut dysmotility
paraventricular
signaling/signaling pathway
stress
Journal
Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481
Informations de publication
Date de publication:
2019
2019
Historique:
received:
15
02
2019
accepted:
13
08
2019
entrez:
27
9
2019
pubmed:
27
9
2019
medline:
27
9
2019
Statut:
epublish
Résumé
Leucine-rich repeat kinase 2 (LRRK2) is a molecule associated with familial and sporadic Parkinson's disease. It regulates many central neuronal functions, such as cell proliferation, apoptosis, autophagy, and axonal extension. Recently, it has been revealed that LRRK2 is related to anxiety/depression-like behavior, implying an association between LRRK2 and stress. In the present study, we investigated for the first time the stress pathway and its relationship to gastrointestinal motility in LRRK2-knockout (KO) mice. The mice were subjected to acute restraint stress, and analyzed for activation of the paraventricular nucleus of the hypothalamus (PVN) using an immunohistochemical approach. Phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) was assessed by Western blotting. The KO mice showed a lower number of c-Fos-positive cells and disruption of the ERK signaling pathway in the PVN in the presence of restraint stress. Stress responses in terms of both upper and lower gastrointestinal motility were alleviated in the mice, accompanied by lower c-Fos immunoreactivity in enteric excitatory neurons. Our present findings suggest that LRRK2 is a newly recognized molecule regulating the stress pathway in the PVN, playing a role in stress-related gastrointestinal dysmotility.
Identifiants
pubmed: 31555076
doi: 10.3389/fnins.2019.00905
pmc: PMC6727664
doi:
Types de publication
Journal Article
Langues
eng
Pagination
905Références
Can J Gastroenterol. 1999 Mar;13 Suppl A:18A-25A
pubmed: 10202204
J Biol Chem. 2001 Apr 13;276(15):11487-95
pubmed: 11139572
Ann Neurol. 2002 Mar;51(3):296-301
pubmed: 11891824
Neurogenetics. 2004 Sep;5(3):147-55
pubmed: 15459824
Neuron. 2004 Nov 18;44(4):595-600
pubmed: 15541308
Trends Biochem Sci. 2005 Mar;30(3):151-9
pubmed: 15752987
J Biol Chem. 2005 Oct 21;280(42):35081-4
pubmed: 16123044
Eur J Neurosci. 2006 Feb;23(3):659-66
pubmed: 16487147
J Neurochem. 2006 Aug;98(3):951-61
pubmed: 16771836
Neuroscience. 2006 Nov 3;142(4):1281-92
pubmed: 16938401
J Neurochem. 2007 Jan;100(2):368-81
pubmed: 17101029
World J Gastroenterol. 2007 Apr 14;13(14):2020-7
pubmed: 17465442
Nat Genet. 2008 Aug;40(8):955-62
pubmed: 18587394
J Neuroendocrinol. 2008 Jun;20(6):880-4
pubmed: 18601712
Neurobiol Dis. 2008 Oct;32(1):116-24
pubmed: 18675914
Am J Physiol Regul Integr Comp Physiol. 2009 May;296(5):R1358-65
pubmed: 19261914
N Engl J Med. 2009 Dec 31;361(27):2609-18
pubmed: 20018961
J Neurosci. 2010 Aug 4;30(31):10360-8
pubmed: 20685979
J Neuroimmunol. 2010 Dec 15;229(1-2):123-8
pubmed: 20728949
J Comp Neurol. 2012 Jan 1;520(1):6-33
pubmed: 21674499
Neurology. 2011 Jul 26;77(4):325-33
pubmed: 21753163
Front Psychiatry. 2011 Jul 06;2:37
pubmed: 21779252
J Neuroendocrinol. 2011 Dec;23(12):1241-51
pubmed: 21929693
Nat Immunol. 2011 Oct 09;12(11):1063-70
pubmed: 21983832
Neurology. 2011 Nov 8;77(19):1761-7
pubmed: 22067963
Hum Mol Genet. 2012 Mar 15;21(6):1350-63
pubmed: 22171073
J Neurosci. 2012 Feb 1;32(5):1602-11
pubmed: 22302802
J Physiol Pharmacol. 2011 Dec;62(6):591-9
pubmed: 22314561
Mol Neurodegener. 2012 May 30;7:25
pubmed: 22647713
Biochem Soc Trans. 2012 Oct;40(5):1102-10
pubmed: 22988873
Neuron. 2012 Sep 20;75(6):1008-21
pubmed: 22998870
Neuron. 2013 Feb 6;77(3):425-39
pubmed: 23395371
Biochem J. 2013 Jul 1;453(1):101-13
pubmed: 23560750
Alcohol Res. 2012;34(4):441-7
pubmed: 23584110
PLoS One. 2013 May 28;8(5):e64943
pubmed: 23724107
Front Integr Neurosci. 2013 Dec 02;7:86
pubmed: 24348350
Nat Neurosci. 2014 Mar;17(3):367-76
pubmed: 24464040
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2626-31
pubmed: 24510904
Front Neuroendocrinol. 2014 Aug;35(3):285-302
pubmed: 24631756
J Neurochem. 2014 Sep;130(6):805-15
pubmed: 24749759
Exp Neurol. 2014 Nov;261:206-16
pubmed: 24907399
EMBO J. 2014 Oct 16;33(20):2314-31
pubmed: 25201882
Gastroenterology. 2014 Dec;147(6):1230-7
pubmed: 25305504
PLoS One. 2014 Oct 17;9(10):e108982
pubmed: 25330404
J Biochem. 2015 Jun;157(6):485-95
pubmed: 25605758
Glia. 2015 Jun;63(6):921-35
pubmed: 25703790
Neurogastroenterol Motil. 2015 Jul;27(7):1010-23
pubmed: 25960044
Parkinsonism Relat Disord. 2015 Dec;21(12):1407-14
pubmed: 26499757
Elife. 2016 Jan 29;5:
pubmed: 26824392
J Neuroimmunol. 2016 Mar 15;292:1-8
pubmed: 26943952
Sci Rep. 2016 Mar 30;6:23673
pubmed: 27026049
Compr Physiol. 2016 Mar 15;6(2):603-21
pubmed: 27065163
BMC Neurosci. 2016 Nov 30;17(1):77
pubmed: 27903237
Dig Dis Sci. 2017 Apr;62(4):903-912
pubmed: 28168579
Biochem Soc Trans. 2017 Feb 8;45(1):261-267
pubmed: 28202680
PLoS One. 2017 Jun 5;12(6):e0179082
pubmed: 28582422
Biochim Biophys Acta Mol Cell Res. 2017 Dec;1864(12):2356-2368
pubmed: 28888991
J Neurosci. 2018 Feb 14;38(7):1611-1621
pubmed: 29305532
J Neurosci. 2018 Feb 21;38(8):1874-1890
pubmed: 29352046
Lancet Neurol. 2018 Apr;17(4):309-316
pubmed: 29456161
J Neuroinflammation. 2018 Oct 27;15(1):297
pubmed: 30368241
Neuron. 1998 Oct;21(4):869-83
pubmed: 9808472